A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

计划入组 50 人 · 首次发布于 2023 年 11 月 2 日

A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)

计划入组 312 人 · 首次发布于 2025 年 5 月 29 日

Group Intervention on Vaccine Confidence

计划入组 429 人 · 首次发布于 2023 年 6 月 7 日

group A Streptococcal vaccine

Group A Meningococcal Polysaccharide Vaccine

Rx

Group A, C meningococcal conjugate vaccine (Beijing Sanroad biological)

The Cigna Group

THE ALBERT B. SABIN VACCINE INSTITUTE, INC.

United States

The Gynecologic Oncology Group

United States

Oxford Study Shows 73% Efficacy for First Paratyphoid A Vaccine Candidate

Clover Reports Positive Phase 2 Data for RSV + hMPV ± PIV3 Combination Vaccines in Older Adults

Oxford Begins First-in-Human Trial of Lassa Fever Vaccine Using COVID-19 Platform Technology